Skip to Main Content (Press Enter)

Logo UNIME
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills

Expertise & Skills
Logo UNIME

|

UNIFIND - Expertise & Skills

unime.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  1. People
Person
COSTA Lara Tania

COSTA Lara Tania

Professoressa associata
Dipartimento di Medicina Clinica e Sperimentale
Course Catalogue:
https://unime.coursecatalogue.cineca.it/docente-ma...

Gruppo 05/BIOS-06 - FISIOLOGIA

Settore BIOS-06/A - Fisiologia
  • Contact
  •  lcosta@unime.it
  • Alerts
  • Agenda
  • Cv
  • Research Fields
  • Outputs
  • Other Activities
  • Courses
  • Office Hours
  • Useful Resources

Communications

Agenda

Attachment (CV)

CV_COSTA_LARA_2024_IRIS.pdf (Curriculum)

Description

Lara Costa has studied the effects of serotonin on synaptic transmission in the hippocampus, showing that activation of 5-HT7 receptors reverses hippocampal mGluR-LTD in wild-type mice and in a mouse model of Fragile X Syndrome. She, also, has studied the use of new synthesis agonists for 5-HT7 receptors as a possible novel therapeutic strategy in FXS and the intracellular pathways activated by 5-HT7 receptors.Now, she is studying the peripheral and spinal processing of pain in on CRND8 mice, the transgenic mouse models of Alzheimer’s Disease. She is investigating the question of whether Aß normally controls pain transmission in the spinal dorsal horn (DH) and if a few number of relevant conditions may intervene to alter this control. She has also characterized the modulatory effects exerted by the endogenous neuropeptide PACAP on AMPA-receptor mediated synaptic currents in the hippocampus and identified the receptors and intracellular messengers involved. She has investigated the consequences of the disrupted mGluR5/Homer crosstalk for the surface dynamics of mGluR5 and consequently for the function and plasticity of NMDA receptors. These studies demonstrate for the first time an alteration in the mGluR5 dynamics at synapses of Fmr1-/y neurons, and its implication in synaptic defects and behavioural phenotypes in Fmr1-/y mice.She has studied the role of PDE2 in synaptic plasticity in physiological conditions and in the animal model of FRAX. She, also, has analyzed the hypothesis that D3 dopamine receptor might be a pharmacological target for procognitive drug treatments, as well as a genetic tool for patient stratification toward more personalized treatments in schizophrenia .She has performed patch clamp recordings from rat hippocampal neurons to test the biological effects of new ligands with high affinity on either AMPA or NMDA receptors for glutamate, with the final objective of finding new pharmacological tools in the therapy of neurodegenerative diseases.

Concepts (8)


LS3_5 - Cell differentiation, physiology and dynamics - (2016)

LS5_1 - Neuroanatomy and neurophysiology - (2013)

LS5_11 - Neurological disorders (e.g. Alzheimer’s disease, Huntington’s disease, Parkinson’s disease) - (2013)

LS5_11 - Neurological disorders (e.g. Alzheimer’s disease, Huntington’s disease, Parkinson’s disease) - (2016)

LS5_2 - Molecular and cellular neuroscience - (2013)

LS5_2 - Molecular and cellular neuroscience - (2016)

LS5_7 - Cognition (e.g. learning, memory, emotions, speech) - (2013)

LS5_7 - Cognition (e.g. learning, memory, emotions, speech) - (2016)

Keywords

SEROTONIN, PATCH CLAMP, PACAP, FRAGILE X SYNDROME, 5HT7 RECEPTOR, AUTISM, LTD, AMPA RECEPTORS
No Results Found

Overview

Lara Costa has studied the effects of serotonin on synaptic transmission in the hippocampus (Costa et al., 2012b) using patch clamp, showing that activation of 5-HT7 receptors reverses hippocampal mGluR-LTD in wild-type mice and in a mouse model of Fragile X Syndrome (Costa et al., 2012a). Now she is studying the use of new synthesis agonists for serotonin type 7 (5-HT7) receptors as a possible novel therapeutic strategy in Fragile X Syndrome (FXS) (Costa et al., Front. Behav. Neurosci.2015) and the intracellular pathways activated by 5-HT7 receptors; she is testing in vitro and in vivo effects of our new compounds on a mouse model of Fragile X Syndrome (Costa et al., 2018). In a new collaboration, she is studying the peripheral and spinal processing of pain in on CRND8 mice, the transgenic mouse models of Alzheimer’s Disease. She is investigating the question of whether Aß normally controls pain transmission in the spinal dorsal horn (DH) and to assess a few number of relevant conditions (i.e, NE-ergic neuronal loss and estrogenic tone) that may intervene to alter this control. Lara Costa has also characterized the modulatory effects exerted by the endogenous neuropeptide PACAP on AMPA-receptor mediated synaptic currents in the hippocampus and identified the receptors and intracellular messengers involved (Costa et al., 2009). In a later study, she has characterized the pre-and post-synaptic effects mediated PAC1 receptors for PACAP and identified a component mediated by release of endogenous acetylcholine (Pecoraro et al., 2017). Lara Costa is investigating the consequences of the disrupted mGluR5/Homer crosstalk for the surface dynamics of mGluR5 and consequently for the function and plasticity of NMDA receptors. These studies demonstrate for the first time an alteration in the mGluR5 dynamics at synapses of Fmr1-/y neurons, and its implication in synaptic defects and behavioural phenotypes in Fmr1-/y mice (Catania et al., 2014; 2014; Aloisi et al., 2017). Moreover, Lara Costa is studying the role of phosphodiesterase PDE2 in synaptic plasticity in physiological conditions and in the animal model of FRAX (in collaboration with Dr. Barbara Bardoni, Maurin et al., 2018). Lara Costa has performed patch clamp recordings from rat hippocampal neurons to test the biological effects of new ligands with high affinity on either AMPA or NMDA receptors for glutamate (Gitto et al., 2008a, 2008b; Gitto et al., 2009; Gitto et al., 2011), with the final objective of finding new pharmacological tools in the therapy of neurodegenerative diseases. Finally, Lara Costa has studied the function of mGlu1 and mGlu5 receptors in neurospheres obtained from the subventricular zone of adult mice. This study has shown that mGlu1b and mGlu5 receptors exert complementary functions in the regulation of survival and proliferation of adult subventricular neural progenitor cells (NPCs), disclosing a novel aspect in the control of NPC biology by glutamate signaling and suggesting new strategies for the therapy of neurodegenerative disorders (Castiglione et al., 2008).
No Results Found

Publications (45)

  • ascendant
  • decrescent
  • All
  • All
  • Open
  • Partially Open
  • Mixed
  • Embargoed
  • Reserved

Other titles (2)

Co-supervisor per la dottoressa Tempio Alessandra nel tesi di dottorato di Ricerca in BIOTECHNOLOGY XXXIV CYCLE presso il DEPARTMENT OF BIOMEDICAL AND BIOTECHNOLOGICAL SCIENCES University of Catania Titolo della tesi Role of 5-HT7 receptors for serotoni (01/04/2022 - 21/07/2022) 20220401
co-Supervisor per la School of Biosciences, Cardiff University per il PTY ( Professional Training Year) della studentessa Holly Griffiths presso il laboratorio di elettrofisiologia Torre Biologica, CT . (01/10/2021 - 30/06/2022) 20211001
No Results Found

Third Mission

Altre iniziative di Public Engagement (Altro) - Il recupero funzionale della performance atletica dello sportivo
Dipartimento di Scienze biomediche, odontoiatriche e delle immagini morfologiche e funzionali
Dipartimento di Medicina Clinica e Sperimentale
Aula Magna - Dipartimento di Veterinaria (05/12/2025 - 05/12/2025) 20251205
No Results Found

Courses (14)

  • ascendant
  • decrescent

1345 - FIRST YEAR FINAL EXAM

CICLO ANNUALE (01/11/2025 - 31/10/2026) - 2025
11 CFU
66 hours

2609 - HUMAN PHYSIOLOGY

CICLO ANNUALE (01/09/2025 - 05/06/2026) - 2025
14 CFU
168 hours

2609 - HUMAN PHYSIOLOGY (AL)

CICLO ANNUALE (01/09/2025 - 05/06/2026) - 2025
14 CFU
168 hours

2609 - HUMAN PHYSIOLOGY (MZ)

CICLO ANNUALE (01/09/2025 - 05/06/2026) - 2025
14 CFU
168 hours

3238 - FUNCTIONAL AND MORPHOLOGICAL BASIS

Primo Semestre (06/10/2025 - 30/01/2026) - 2025
7 CFU
42 hours

3238/3 - Physiology

Primo Semestre (06/10/2025 - 30/01/2026) - 2025
2 CFU
12 hours

3238/4 - Neurophysiology

Primo Semestre (06/10/2025 - 30/01/2026) - 2025
1 CFU
6 hours

3240 - MOVEMENT SCIENCE

Secondo Semestre (30/03/2026 - 30/05/2026) - 2025
6 CFU
36 hours

3240/4 - Physiology of movement

Secondo Semestre (30/03/2026 - 30/05/2026) - 2025
1 CFU
6 hours

3311 - BIOCHEMICAL AND PHYSIOPATHOLOGICAL SCIENCES

Secondo Semestre (25/03/2026 - 04/06/2026) - 2025
6 CFU
36 hours

4147 - MORPHOLOGICAL AND FUNCTIONAL FOUNDATIONS IN HUMAN APPARATUS

Primo Semestre (01/10/2025 - 31/01/2026) - 2025
9 CFU
54 hours

3311/2 - FISIOLOGIA

Secondo Semestre (25/03/2026 - 04/06/2026) - 2025
2 CFU
12 hours

4147/2 - FISIOLOGIA

Primo Semestre (01/10/2025 - 31/01/2026) - 2025
3 CFU
18 hours

UU-692 - FISIOLOGIA

CICLO ANNUALE (01/11/2025 - 31/10/2026) - 2025
1 CFU
6 hours
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} of {itemsNumber}

Office Hours

Video

Useful Resources

  • Guide
  • Help
  • Accessibility
  • Privacy
  • Use of cookies
  • Legal notes

Powered by VIVO | Designed by Cineca | 26.3.5.1